FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Memantine Hydrochloride (NAMENDA) Oral Solution
Status: Discontinuation
»Therapeutic Categories: Neurology

Forest Laboratories, Inc. (New 12/14/2017)

Company Contact Information:

Presentation Posting Date Related Information
NAMENDA (memantine HCl) Oral Solution, 2mg/ml, Packaging: 12 fl. oz. (360 mL) bottle (NDC 00456-3202-12) 12/14/2017

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English